House Bill 1409
115th Congress(2017-2018)
Cancer Drug Parity Act of 2017
Introduced
Introduced in House on Mar 7, 2017
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
1409
Congress
115
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Leonard Lance
grade
New Jersey
Alaska
Arizona
Arizona
Arizona
Arizona
California
California
California
California
California
California
California
California
California
California
California
California
California
California
California
California
California
California
Colorado
Colorado
Connecticut
Connecticut
Connecticut
District of Columbia
Florida
Florida
Florida
Florida
Florida
Florida
Florida
Florida
Florida
Florida
Georgia
Georgia
Georgia
Georgia
Georgia
Georgia
Georgia
Georgia
Hawaii
Illinois
Illinois
Illinois
Illinois
Illinois
Illinois
Illinois
Illinois
Indiana
Indiana
Iowa
Iowa
Kansas
Kentucky
Kentucky
Louisiana
Maine
Maine
Maryland
Maryland
Maryland
Maryland
Massachusetts
Massachusetts
Massachusetts
Massachusetts
Massachusetts
Massachusetts
Michigan
Michigan
Michigan
Michigan
Michigan
Michigan
Michigan
Michigan
Minnesota
Minnesota
Mississippi
Mississippi
Mississippi
Missouri
Missouri
Missouri
Missouri
Montana
Nebraska
Nebraska
Nevada
Nevada
New Hampshire
New Jersey
New Jersey
New Jersey
New Jersey
New Mexico
New Mexico
New York
New York
New York
New York
New York
New York
New York
New York
New York
New York
New York
New York
New York
North Carolina
North Carolina
North Carolina
North Carolina
North Dakota
Ohio
Ohio
Ohio
Ohio
Ohio
Ohio
Ohio
Oregon
Oregon
Oregon
Pennsylvania
Pennsylvania
Pennsylvania
Pennsylvania
Pennsylvania
Pennsylvania
Pennsylvania
Pennsylvania
Pennsylvania
Pennsylvania
Pennsylvania
Puerto Rico
Rhode Island
South Carolina
South Carolina
Tennessee
Tennessee
Tennessee
Tennessee
Texas
Texas
Texas
Texas
Texas
Texas
Texas
Texas
Texas
Virginia
Virginia
Virginia
Virginia
Washington
Washington
Washington
Washington
West Virginia
Wisconsin
Wisconsin
Wisconsin
Wisconsin
Wisconsin
No House votes have been held for this bill.
Summary
Cancer Drug Coverage Act of 2017
This bill amends the Public Health Service Act to require group and individual health plans that cover anticancer medications administered by a health care provider to provide no less favorable cost sharing for patient-administered anticancer medications. This requirement applies to medication approved by the Food and Drug Administration that is prescribed based on a finding by the treating physician that the medication is medically necessary for cancer treatment and is clinically appropriate in terms of type, frequency, extent site, and duration.
To comply with this requirement, health plans may not, for anticancer medications: (1) change or replace benefits to increase out-of-pocket costs; (2) reclassify benefits to increase costs; or (3) apply more restrictive limitations to orally administered medications than to intravenously administered or injected medications.March 7, 2017
03/17/2017
Referred to the Subcommittee on Health.
03/07/2017
Referred to the House Committee on Energy and Commerce.
03/07/2017
Introduced in House
Public Record
Record Updated
Jan 11, 2023 1:35:43 PM